TCP1 and breast cancer: Therefore, we transiently transfected MDA-MB-231/alisertib and BT-549/alisertib cells, which have considerably greater TCP1 expression, with TCP1-specific siRNA vector to reduce TCP1 expression to investigate whether the cellular TCP1 level is connected to the resistance of BC cells to alisertib.